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Approximately 20% of women acknowledge smoking dur-
ing pregnancy in the United States (National Survey on Drug 
Use and Health; Office of Applied Studies, 2005), which results 
in at least 500,000 prenatally tobacco-exposed infants annu-
ally. Smoking during pregnancy is substantially more prev-
alent than prenatal use of alcohol or illicit drugs. For most 
women, smoking is a daily habit that, when pregnant, results 
in a regular dosing pattern to the fetus. As such, prenatal to-
bacco exposure carries broad risk for harm and potential mor-
bidity (Koren, 1993; Slotkin, 1998b). 
Tobacco contains a number of chemically active com-
pounds. Nicotine appears to be the predominant contribu-
tor to the impact on growth and behavior of children exposed 
during pregnancy. Nicotine is a powerful vasoconstrictor that 
reduces the flow of available nutrients and oxygen to the de-
veloping fetus. Indeed, exposure-related reductions in birth 
weight have been reported in the literature for several de-
cades. Besides birth weight, prenatal tobacco exposure is also 
associated with dose-dependent reductions in body length 
and head size (e.g., Hardy & Mellits, 1972; Rantakallio, 1983; 
Roza et al., 2007; Vik, Jacobsen, Vatten, & Bakketeig, 1996). 
These exposure-related physical growth differences at birth 
usually resolve by the infant’s first birthday (Conter, Corti-
novis, Rogari, & Riva, 1995; Day et al., 1992; Hardy & Mellits, 
1972). The physical growth deficits and the associated tobacco-
exposure–related increase in perinatal complications both con-
tribute to, but do not completely account for, a greater risk for 
attention-deficit/hyperactivity disorder (Nigg & Breslau, 2007; 
Szatmari, Saigal, Rosenbaum, Campbell, & King, 1990; Wil-
loughby, Greenberg, Blair, Stifter, & Family Life Investigative 
Group, 2007). 
Although largely ignored for decades, nicotine is also a 
psychoactive compound that acts directly on the brain. Nic-
otine activates nicotinic acetylcholine receptors that are sit-
uated on dopamine neurons in the striatum and noradrener-
gic neurons in the locus coeruleus (Lichtensteiger et al., 1982) 
and are present as early as eight weeks gestation (Hagino & 
Lee, 1985). In elegant preclinical work in nonhuman animals, 
prenatal tobacco exposure has been found to disrupt the tim-
ing of cholinergic synaptic activity during key developmen-
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Abstract 
Smoking during pregnancy is a persistent public health problem that has been linked to later adverse outcomes. The neonatal pe-
riod—the first month of life—carries substantial developmental change in regulatory skills and is the period when tobacco metabo-
lites are cleared physiologically. Studies to date mostly have used cross-sectional designs that limit characterizing potential impacts 
of prenatal tobacco exposure on the development of key self-regulatory processes and cannot disentangle short-term withdrawal 
effects from residual exposure-related impacts. In this study, pregnant participants (N = 304) were recruited prospectively during 
pregnancy, and smoking was measured at multiple time points, with both self-report and biochemical measures. Neonatal attention, 
irritable reactivity, and stress dysregulation were examined longitudinally at three time points during the first month of life, and 
physical growth indices were measured at birth. Tobacco-exposed infants showed significantly poorer attention skills after birth, 
and the magnitude of the difference between exposed and nonexposed groups attenuated across the neonatal period. In contrast, ex-
posure-related differences in irritable reactivity largely were not evident across the 1st month of life, differing marginally at 4 weeks 
of age only. Third-trimester smoking was associated with pervasive, deleterious, dose–response impacts on physical growth mea-
sured at birth, whereas nearly all smoking indicators throughout pregnancy predicted level and growth rates of early attention. The 
observed neonatal pattern is consistent with the neurobiology of tobacco on the developing nervous system and fits with develop-
mental vulnerabilities observed later in life.
Keywords: prenatal tobacco exposure, self-regulation, longitudinal modeling
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tal periods, to alter receptor-mediated processes controlling 
cell replication and differentiation (Slotkin, 1998a), and to re-
sult in abnormal neuronal reactivity (Landmesser, 1994; Na-
varro, Seidler, Whitmore, & Slotkin, 1988; Seidler, Levin, 
Lappi, & Slotkin, 1992; Slotkin, Lappi, & Seidler, 1995), in-
cluding the disruption of developing dopaminergic circuits 
(Azam, Chen, & Leslie, 2007). When administered prenatally, 
nicotine reduces postnatal dopaminergic activity in the ven-
tral tegmental area, nucleus accumbens, and striatum (Chen, 
Parker, Matta, & Sharp, 2005; Muneoka et al., 1997; Slotkin, 
1998b), with a corresponding reduction in D2 dopamine re-
ceptors (S. A. Richardson & Tizabi, 1994). Serotonergic sys-
tems are affected similarly, as prenatal tobacco exposure dis-
rupts paroxetine binding to the 5-HT transporter (Levin & 
Slotkin, 1998). These disruptions persist well after nicotine 
exposure has ceased (McFarland, Seidler, & Slotkin, 1991), 
suggesting that prenatal nicotine exposure alters cell devel-
opment programs in an irreversible manner (Slotkin, 1998b) 
that is not attributable solely to the hypoxic effects of nico-
tine on the central nervous system (Slotkin, Greer, Faust, 
Cho, & Seidler, 1986). 
Given the strong link between alterations of the dopami-
nergic and serotonergic brain systems and developmental 
psychopathology, it may not be surprising that many studies 
have linked prenatal tobacco exposure to externalizing behav-
iors in childhood (e.g., Day, Richardson, Goldschmidt, & Cor-
nelius, 2000; Wakschlag, Leventhal, Pine, Pickett, & Carter, 
2006) and to the clinical diagnoses of attention-deficit/hyper-
activity disorder and oppositional defiant disorder (Huizink 
& Mulder, 2006; Kotimaa et al., 2003; Orlebeke, Knol, & Ver-
hulst, 1999; Wakschlag, Pickett, Cook, Benowitz, & Leven-
thal, 2002). Furthermore, self-reported prenatal smoking also 
has been associated with inattention, overactivity, and an im-
pulsive response style at preschool and early school age (Day 
et al. 2000; Fried, Watkinson, & Gray, 1992; Johnson, Vicary, 
Heist, & Corneal, 2001; Leech, Richardson, Goldschmidt, & 
Day, 1999), working memory and inhibition deficits in ado-
lescents (Bennett et al., 2009; Fried & Watkinson, 2001; Jacob-
sen, Slotkin, Westerveld, Mencl, & Pugh, 2006), and negative 
emotionality in infants and young children (Brook, Brook, 
& Whiteman, 2000; Fried & Makin, 1987; Kelmanson, Er-
man, & Litvina, 2002; Schuetze & Eiden, 2007; Wakschlag & 
Hans, 2002; Willoughby, Greenberg, Blair, Stifter, & Family 
Life Investigative Group, 2007). Dose–response relations be-
tween prenatal tobacco exposure and such externalizing be-
haviors have been reported (e.g., Day et al., 2000; Linnet et 
al., 2003; Williams et al., 1998). Generally, the effect of expo-
sure on these outcomes is robust but may be reduced in mag-
nitude when adjusted for confounding environmental and ge-
netic covariates (Linnet et al., 2003; Maughan, Taylor, Caspi, 
& Moffitt, 2004; Rodriguez & Bohlin, 2005; Thapar et al., 2003) 
or is eliminated in epidemiological within-family, sibling de-
signs (e.g., D’Onofrio et al., 2007). 
Results of studies conducted on newborns in the 1970s and 
1980s with self-reported measures of smoking suggest expo-
sure-related vulnerabilities in self-regulation. Saxton (1978) ex-
amined infant behavior shortly after birth in a small sample 
of infants born to women who smoked 15 or more cigarettes 
per day. Tobacco-exposed neonates showed reduced sensitiv-
ity to auditory stimuli, evidenced by greater auditory habit-
uation and poorer orientation to auditory inanimate and ani-
mate stimuli. Other researchers (Fried, Watkinson, Dillon, & 
Dulberg, 1987; Picone, Allen, Olsen, & Ferris, 1982) confirmed 
these findings and noted reductions in visual attention skills 
(S. W. Jacobson, 1984; G. A. Richardson, Day, & Taylor, 1989; 
Streissguth, Sampson, Barr, Bookstein, & Carmichael, 1994). 
Alterations in state behavior (i.e., increased irritability; Fried 
& Makin, 1987; S. W. Jacobson, 1984; Stroud, Paster, Goodwin, 
et al., 2009), disrupted cry (Nugent, Lester, Greene, & Wiec-
zorek-Deering, 1996), and autonomic regulation (Picone et al., 
1982) also have been associated with prenatal tobacco expo-
sure, although not in all studies (G. A. Richardson et al., 1989). 
More recently, a handful of studies that included bioassay val-
idation of exposure confirmed differences in withdrawal be-
haviors (heightened irritability, physiologic signs of stress) in 
the first few days of life (Godding et al., 2004; Law et al., 2003; 
Mansi et al., 2007) and hint at persistent differences later in the 
neonatal period in reactivity to handling (Stroud, Paster, Pa-
pandonatos, et al., 2009). 
Despite its relative temporal brevity, there is substantial 
skill development in the neonatal period. Shortly after birth, 
the newborn works to independently achieve physiologi-
cal stability and homeostasis, including regulation of arousal 
(Kopp, 1982; Riese, 1987). After homeostasis is achieved, the 
neonate regulates responsiveness to external stimuli through 
state modulation and directed orientation of attention (Bard, 
Coles, Platzman, & Lynch, 2000; Emde & Buchsbaum, 1989). 
Investigations that have focused on behavior shortly after 
birth likely do not fully capture the impacts of prenatal ex-
posure on skill development across the period. From the per-
spective of exposure, the neonatal period begins with physio-
logical clearing of nicotine and other tobacco compounds from 
maternal smoking late in pregnancy, where both exposure 
and withdrawal effects are evident shortly after birth. Later in 
the neonatal period, the persistent, residual impacts of expo-
sure on neurobehavior can be observed without the confound-
ing of short-term withdrawal behaviors. Furthermore, because 
behavioral manifestations of brain alterations may not be evi-
dent until the age at which the compromised area is called into 
action for skill execution (Goldman, 1974), in some cases long 
after the damage occurred, new insights can be gained by ex-
amining exposure-related outcome with repeated measure-
ments. For the neonatal period, longitudinal designs permit 
characterization of how prenatal tobacco alters the develop-
mental trajectory of regulatory skills and can help to disentan-
gle short-term withdrawal from the more persistent, residual 
effects of exposure. 
Indeed, results from a handful of studies hint at persis-
tent differences later in the neonatal period. Fried and Ma-
kin (1987), for example, found greater impairment in tobacco-
exposed infants in motor response at 30 days of age than at 9 
days of age. More recently, Stroud, Paster, Papandonatos, et 
al. (2009) examined the impact of prenatal tobacco exposure 
on the regulatory behavior of 56 neonates at 10 to 27 days. Ex-
posed neonates did not differ from their socioeconomic status 
(SES)- and alcohol exposure–matched peers in stress responses 
or muscle tone, but exposed infants exhibited a greater need 
for handling and scored lower on self-regulation items. In a 
large sample of White and Black infants, the amount of expo-
sure indexed by maternal serum cotinine was related to dif-
ferences in arousal and regulation at 5 weeks of age (Yolton 
et al., 2009). To date, no studies have leveraged longitudi-
nal data to examine exposure-related differences across early 
development. 
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The purpose of the present study, then, was to delineate 
the impact of prenatal tobacco exposure on the early develop-
ment of emergent regulatory processes across the first month 
of life—the neonatal period—using a prospective, cohort de-
sign with self-reported and bioassay indices of exposure col-
lected repeatedly during pregnancy. Using hierarchical growth 
modeling, we could then parse the effect of prenatal tobacco 
exposure into effects that influence the level of self-regulatory 
behavior at any given age and those that influence the rate of 
behavior change or development to better characterize the im-
pact of exposure on the underlying developmental process. 
This modeling approach previously has been demonstrated 
to be useful. For example, Espy, Riese, and Francis (1997) ob-
served that prenatal cocaine exposure differentially affected 
the developmental level and rate parameters. Building on ex-
tant findings, we hypothesized that tobacco-exposed neonates 
would show reduced self-regulatory skills after birth, mani-
fested by poorer attention and orientation, increased irritabil-
ity and greater stress dysregulation, as well as persistent expo-
sure-related differences at 4 weeks of age. Because our study 
was motivated by a neural systems perspective to better char-
acterize specific tobacco exposure effects, we were particularly 
interested in isolating the impact of tobacco exposure as much 
as possible and thus used strict participant selection proce-
dures to minimize other exposures and influences. With these 
selection methods, we postulated that differences in self-reg-
ulatory behaviors would be related in a dose–response man-
ner to the number of cigarettes smoked by the mother dur-
ing pregnancy, indexed by self-report and bioassays at each 
trimester. We also examined exposure-related differences in 
physical growth at birth, as these indices have been shown to 
be important mediators in other behavioral teratologic studies 
(e.g., head circumference and prenatal cocaine exposure; Eyler, 
Behnke, Conlon, Woods, & Wobie, 1998). Finally, exposure-re-
lated differences in the development of rudimentary self-regu-
latory processes were explored by evaluating differences in the 
rate of skill growth across the entire neonatal period. 
Method
Participants 
The sampling strategy was designed to compare two neo-
natal groups—tobacco exposed and nonexposed groups—and 
to minimize the influences of other exposures and sociodemo-
graphic differences. Consistent with this objective, study flyers 
were distributed over a 4.5-year period to all obstetric clinics 
in two sites in the Midwest: rural multicounty area in south-
ern Illinois (surrounding the town of Carbondale) and a small-
sized city (Lincoln, Nebraska). Interested pregnant women (N = 
915) called the laboratory and were screened for study eligibil-
ity with questions regarding due date, educational attainment, 
maternal race, smoking history and status, alcohol and illegal 
drug use, and (as a less intrusive proxy for income) Medicaid 
status. Women who reported at screening (a) illegal drug use 
or (b) alcohol use of four or more drinks on a single occasion 
(criterion for binge drinking; Centers for Disease Control, 2008) 
were eliminated as ineligible at screening and were not consid-
ered further for potential recruitment. Among screened women 
who reported no binge drinking and no illegal drug use, all 
women who reported smoking in the month around their last 
menstrual period or current active smoking on the screening 
were then recruited, enrolled, and preliminarily classified as to-
bacco exposed. Smoking at last menstrual period was chosen 
as the criterion to capture women who underdisclose smoking 
during very early pregnancy, when in fact, they quit smoking 
upon learning they were pregnant (which is well into the preg-
nancy period) and would therefore have been classified erro-
neously as nonexposed (England et al., 2007). Among screened 
women who reported no binge drinking, no illegal drug use, 
and no smoking at screening, those with lower educational at-
tainment (<14 years), majority race/ethnicity, and Medicaid sta-
tus were overselected for subsequent recruitment to render the 
groups more comparable demographically given the known 
higher frequency of smoking in these groups (N = 387 before 
data exclusions described below). Most participants (65%) were 
enrolled prior to the 16th prenatal week, and all women were 
enrolled prior to the 28th prenatal week. Women’s self-reported 
prenatal smoking behavior then was obtained prospectively at 
16 weeks, 28 weeks, and delivery (hereinafter referred to as 40 
weeks), with a modified timeline follow-back method (Sobell & 
Sobell, 1992), where dates were used to cue recall and smoking 
was queried month by month. 
Next, self-reported smoking behavior was examined for 
consistency with the initial group assignment. Where smoking 
status was consistent across the interviews and agreed with 
the last smoking date (if applicable), the exposure group as-
signment remained. For those who did not meet either of these 
criteria, the reported last smoking dates across the interviews 
were examined with regard to proximity of last menstrual pe-
riod. If a participant was classified initially as nonexposed 
but reported last smoking dates falling within the window of 
pregnancy, then that participant was reclassified as tobacco 
exposed. Ten smokers reported no cigarette use during preg-
nancy that was inconsistent with their last menstrual period 
and reported last smoking dates. For these women, the miss-
ing average smoking amounts for the applicable trimesters 
were imputed with regression modeling (Little & Rubin, 2002). 
The results of the biospecimen sampling were then examined 
to confirm smoking group assignment. We created plots of the 
cotinine levels, the nicotine by-product that was assayed by 
U.S. Drug Laboratories from samples collected from maternal 
urine at 16, 28, and 40 weeks of the pregnancy and from in-
fant meconium shortly after birth (see Procedures for further 
details). Any nonsmoking woman with at least one urine coti-
nine value of 30 ng/ml or greater or whose infant had a meco-
nium cotinine level of at least 30 ng/g was scrutinized further. 
Two mothers were reclassified as tobacco exposed who had at 
least one urine or infant meconium cotinine level greater than 
100, the cutoff value recommended by U.S. Drug Laboratories. 
Because the purpose of this article was to examine the im-
pact of prenatal tobacco exposure while minimizing con-
founding influences and other exposures, data from women/
neonates who met one of the four following criteria were ex-
cluded from analysis. First, although women who reported 
illegal drug use during screening were not recruited or en-
rolled, 53 women denied use at screening and then subse-
quently reported use of marijuana at a prenatal interview 
(n = 38) or their infant’s meconium tested positive for mari-
juana at birth (n = 19). Second, one woman reported prescrip-
tion antipsychotic medication use during pregnancy, which 
has known negative impacts on neonatal behavior. Because 
women who smoke are also more likely to drink, and to drink 
more in one sitting, than nonsmokers, we carefully measured 
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alcohol use around the last menstrual period and during each 
month of pregnancy with the same structured, timeline fol-
low-back methods as for smoking, querying about quantity, 
frequency, and variability. In the present sample, 83% of the 
women in the tobacco-exposed group reported drinking be-
fore pregnancy and prior to their last menstrual period com-
pared with 61% percent of women in the nonexposed group, 
χ2(1, N = 304)_18.51, p < .0001. Furthermore, the average num-
ber of alcoholic drinks consumed per day during the first tri-
mester of pregnancy differed between tobacco-exposed and 
nonexposed groups (shown in Table 1), as well as comparison 
of groups among drinkers only: for tobacco-exposed drinkers 
only, M = 0.18; SD = 0.23; for nonexposed drinkers only, M = 
0.04, SD = 0.06; t(150) = –4.80, p < .0001. The data also were 
excluded for eight women who reported at the first interview 
drinking one or more drinks per day on average (criteria for 
heavy drinking; Centers for Disease Control, 2008) for the first 
trimester. Only those with heavy drinking in the first trimes-
ter were excluded because, after removing the data from these 
eight women, we found that 85% of participants reported no 
alcohol use after the end of the first trimester. Furthermore, 
the amount and frequency of alcohol use in those who re-
ported use after the first trimester was no more than one drink 
on one specifically identified occasion (e.g., a holiday or birth-
day) for all but six women (Trimester 2, M = 0.028, SD = 0.028; 
Trimester 3, M = 0.076, SD = 0.082). Mean number of alcoholic 
drinks consumed per day reported for both the second and 
third trimesters for each exposure group (in Table 1) was very 
low, as well as when comparing groups among drinkers only 
(tobacco-exposed drinkers only: Trimester 2, M = 0.004, SD = 
0.009; Trimester 3, M = 0.002, SD = 0.009; nonexposed drink-
ers only: Trimester 2, M = 0.007, SD = 0.026; Trimester 3, M 
= 0.002, SD = 0.010). Although our focus was on prenatal to-
bacco exposure while minimizing other exposures, we elected 
not to exclude the data from women who consumed any al-
cohol (even though in relatively low amounts in this sample) 
to conserve sample size and preserve generalizability because 
of the common comorbidity of smoking and alcohol use, par-
ticularly prior to pregnancy detection. Therefore, we included 
prenatal alcohol use during the first trimester as a potential 
covariate (see Procedures section below for further details). Fi-
nally, to minimize the well-known influence of gestational age 
on self-regulatory behavior (Korner, Brown, Dimiceli, & For-
rest, 1989; Riese, Wilson, & Matheny, 1985), data from 10 in-
fants born preterm (before 36 weeks) also were removed. Of 
the 10 removed, eight were tobacco exposed. 
A total of 304 women and their infants met the criteria for 
inclusion, with 143 infants classified as tobacco exposed and 
161 as nonexposed (138 women/infants from the rural Illinois 
site and 166 women/infants from the urban Nebraska site, 
Table 1. Maternal Variables by Tobacco Exposure Group
                                                                                                                t test                                 Tobacco exposed                           Nonexposed
Maternal demographic, health, and perinatal variables           t              (df)                       M               SD           %               M               SD            %
Maternal age at delivery (years)  2.08*  (302)  25.3  5.0   26.5  5.0
Maternal education (years)  4.51***  (302)  13.01  1.61   13.89  1.75
Median monthly family income ($)    1,742    1,820
Gravida  –1.29  (302)  1.77  2.21   1.50  1.41
Parity  0.33  (302)  1.04  1.33   1.09  1.05
Weight gain (first prenatal visit to delivery)  –1.74  (301)  27.7  15.5   24.7  14.5
Anemia      14    16
Medicaid      84    83
Married **      36    54
Placental abruption      0.3    0.0
Delivery
    Spontaneous vaginal      41    54
    Induced vaginal      27    28
    Caesarean and other extraction      32    18
Asthma medication      4    6
Pain medication      22    17
Antidepressant medication      12    9
Diabetes      6    7
Hypertension/pre-eclampsia      11    14
Infection      11    11
Heart disease      4    3
Thyroid disease      1    4
WJ-III BIA overall IQ estimate  2.88**  (297)  95.52  10.77   99.23  12.29
BSI General Severity Index T score  –1.77  (300)  57.04  8.39   55.34  8.39
CAARS Attention Deficit/Hyperactivity Disorder T score  –0.87  (300)  46.74  8.26   45.96  7.87
Maternal prenatal drinking (drinks/day)
    Trimester 1 average  –6.77***  (300)  0.127  0.206   0.015  0.038
    Trimester 2 average  –2.15*  (301)  0.003  0.008   0.001  0.006
    Trimester 3 average  –2.30*  (302)  0.004  0.022   0.001  0.006
WJ-III BIA = Woodcock–Johnson III Brief Intellectual Ability Assessment (Woodcock, Johnson, & Mathers, 2001); BSI = Brief Symptom Inventory 
(Derogatis, 1975); CAARS = Conners Adult ADHD Rating Scale, Short (Conners, Erhardt, & Sparrow, 1998).
*  p < .05 ;  **  p < .01 ;  ***  p < .001.
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where exposure groups by site were comparable).1 The sample 
included 235 White, non-Hispanic women (77.3%); 15 White, 
Hispanic women (4.9%); 40 African American women (13.2%); 
and 9 Native American women (3.0%). On average, mothers 
completed 13.5 years of education (SD = 1.7). Although lan-
guage spoken in the home was not collected, all women were 
proficient English speakers. Women in the tobacco-exposed 
and nonexposed groups were comparable in the percentage 
receiving Medicaid assistance but differed in the proportion 
married at enrollment, age at delivery, and educational attain-
ment. There were no differences between exposure groups 
in the proportion of female infants, infant gestational age at 
birth, or infants who were of White, non-Hispanic race/eth-
nicity. Tables 1 and 3 depict the respective descriptive statis-
tics for women and neonate participants by exposure group.
Procedures 
Tobacco exposure. Women were interviewed with the 
structured, timeline follow-back method in a private room by 
trained researchers (the research technicians who conducted 
interviews were not the same as those who conducted neona-
tal evaluations to ensure blind assessment) at 16, 28, and 40 
weeks (just after delivery) to gain information on prenatal to-
bacco and alcohol use. The comprehensive interview included 
background and other health-related questions, as well as que-
ries about quantity, frequency, and variability information re-
garding tobacco and alcohol use by month. These month-by-
month values were averaged into trimester indices. At each 
session, women provided a urine sample in a sterile cup, 
where 100% of women provided samples at the 16-week in-
terview, 99% at 28 weeks, and 96% at delivery, as occasionally 
women had difficulty providing a sufficiently clean sample 
for cotinine assay after delivery. After the neonate was born, 
nurses collected meconium samples until a total weight of 25 
g was obtained. However, some neonates voided meconium in 
utero or during delivery, preventing collection of an adequate 
volume of meconium for later assay. A total of 255 neonate 
meconium cotinine results were available for analysis. 
Once nicotine is absorbed by the mother during smoking, 
it is metabolized into cotinine and is detectable in the urine up 
to several days after the termination of smoking. To measure 
cotinine level in participants’ urine samples, we used the DRI 
Cotinine Assay from U.S. Drug Laboratories. The DRI cotinine 
assay is a liquid, ready-to-use homogeneous enzyme immu-
noassay based on competition between cotinine labeled with 
glucose-6-phosphate dehydrogenase enzyme and free coti-
nine in the sample for a fixed amount of cotinine-specific an-
tibody binding sites. The glucose- 6-phosphate dehydrogenase 
enzyme activity is determined spectrophotometrically at 340 
nm by measuring its ability to convert nicotinamide adenine 
dinucleotide (NAD) to NAD-hydrogenase. This assay utilizes 
DRI cotinine calibrators and controls, which are prepared by 
spiking negative human urine with a known quantity of coti-
nine. The cotinine concentration is obtained by running a stan-
dard curve with the appropriate calibrators and by quantitat-
ing samples off the standard curve. 
The tobacco exposure information is provided in Table 2. 
A total of 43% of the tobacco-exposed group reported smok-
ing 10 or more cigarettes per day on average before pregnancy 
and prior to the last menstrual period. The average number 
of cigarettes smoked during each trimester and at the 16-, 28-, 
and 40-week interviews was substantially less, between three 
and six cigarettes per day. Although 39% of the women re-
ported that they no longer smoked by the end of the first tri-
mester and 50% reported no longer smoking by the end of the 
second trimester, the average maternal urinary cotinine val-
ues for the tobacco-exposed group at 28 weeks did not differ 
from those collected at 16 weeks: 16 weeks, M = 331 ng/mL, 
SD = 537; 28 weeks, M = 353 ng/mL, SD = 564, t(87) = –0.72, 
p > .45. The lowest average cotinine value for the tobacco-ex-
posed group was at delivery. The average cotinine values for 
the nonexposed group were less than 15 ng/ml across all occa-
sions. As expected, the mean cotinine values in maternal urine 
and neonate meconium differed between the tobacco-exposed 
and nonexposed groups at all time points (all ps < .01). Table 4 
provides intercorrelations of the self-reported smoking behav-
ior variables and the cotinine assay results at all time points. 
Neonate urine samples were collected from soft cloths in-
serted into the diaper at the 2- and 4-week sessions to assess 
environmental tobacco smoke exposure. U.S. Drug Laborato-
ries conducted the DRI cotinine assay on these postnatal urine 
samples. Tobacco-exposed and nonexposed group mean 2- 
and 4-week neonate urinary cotinine levels did not differ and 
are shown in Table 2. 
Neonatal assessment. Although the state ratings, auditory 
and visual stimuli, and reflex maneuvers are similar among 
most neonatal instruments as a result of the limited behav-
ioral repertoire of the young neonate, we chose the Neonatal 
Temperament Assessment (NTA) to measure emergent regu-
latory skills because of its unique modules that include graded 
stressors designed to probe the regulatory system and known 
psychometric properties. Psychometric properties of the NTA 
have been reported as good (Riese, 1982), where interrater re-
liability and internal consistency range from 0.85 to 0.97 and 
0.72 to 0.86, respectively (Riese, 1983). We calculated interra-
ter reliabilities from coscoring 4% of all assessments adminis-
tered, with obtained reliabilities ranging from .89 to .99. With 
regard to predictive validity, Riese and colleagues (Matheny, 
Riese, & Wilson, 1985; Riese, 1995; Riese, Wilson, & Matheny, 
1985) have shown that neonatal temperament is related to 
later maternal reports and direct laboratory behavioral obser-
vations of infant temperament at 6 months, 9 months, and 2 
years. In these studies, those who were more irritable perina-
tally were rated as more upset, more variably active, less at-
tentive to stimuli, and less responsive (Riese, 1987). 
Research technicians administered the standardized NTA, 
which was designed to evaluate individual differences in 
early regulatory behaviors three times in the neonatal pe-
riod, at 0.2 weeks (about two days) after birth in the hospi-
tal, at 2 weeks of age in the university laboratory and at 4 
weeks of age in the participant’s home. Following the work 
1. Recruitment was balanced across sites, as the interaction of site by exposure group was not significant for nearly all demographic, maternal, and 
perinatal variables. The only exception was that there were more nonsmoking women enrolled at the Illinois site who had private insurance, 
χ2(1, N = 304) = 7.97, p < .01. A total of 23 nonexposed–Illinois, 4 nonexposed–Nebraska, 11 tobacco-exposed–Illinois, and 12 tobacco-exposed– 
Nebraska participants had private insurance.
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of Riese (1982, 1986), research technicians were taught ini-
tially in handling and working with neonates and then were 
trained in how to administer the NTA items. Before comple-
tion of training, each research technician achieved an initial 
reliability of greater than 90% with at least 10 neonates (de-
termined by double coding of assessments). Random cases 
(10%) were selected for double coding throughout the study 
to ensure that ongoing reliability in administration remained 
above 90%. The NTA author conducted the extended, initial 
training session for study staff at the beginning of the study 
and one additional follow-up session during the study. To 
maintain blindness to tobacco-exposure group membership, 
we designed the study so that examiners who conducted the 
interviews with the mothers were different than those who 
conducted the NTA assessments with the neonates. How-
ever, it was impossible to keep the examiners uninformed of 
tobacco use in the home at the 4-week assessment that was 
conducted in the home, although tobacco use in the home 
is not an indicator of prenatal exposure group membership 
per se. Neonates averaged 0.2 weeks of age (SD = 0.14) at the 
birth assessment, 2.24 weeks (SD = 0.40) at the 2-week assess-
ment, and 4.22 weeks (SD = 0.47) at the 4-week assessment. 
Gestational ages at birth were corrected such that the 2- and 
4-week assessments were scheduled to equate conceptional 
age. The age range window was ±1 week at the 2-week as-
sessment and ±1.5 weeks for 4-week assessment. There were 
no age differences at any assessment between tobacco-ex-
posed and nonexposed groups (all ps > .05). 
Table 2. Maternal Smoking and Infant Exposure Variables by Tobacco Exposure Group
                                                                                                                      t test                               Tobacco exposed                            Nonexposed
Tobacco-related variable                                                                       t          (df)                      M              SD          % (n)                      M            SD
Maternal self-reported prenatal smoking (no. of cigarettes/day)
Trimester 1    5.32  5.74
    At 16-week interview    3.62  6.21
Trimester 2    3.84  6.17
    At 28-week interview    3.80  6.31
Trimester 3    3.44  6.18
    At 40-week interview    3.04  6.07
Cotinine level
16-week maternal urine (ng/ml)  –6.27***  (195)  330.90  536.60   5.64  13.78
28-week maternal urine (ng/ml)  –7.71***  (300)  352.89  563.65   10.40  18.22
    At delivery maternal urine (ng/ml)  –4.49***  (291)  83.85  198.27   12.06  19.12
    At delivery neonate meconium (ng/g)  –2.63***  (249)  192.74  856.51   0.39  3.43
2-week infant urine cotinine (ng/ml)  –1.55  (259)  21.67  32.14   16.32  23.27
4-week infant urine cotinine (ng/ml)  –1.54  (255)  39.80  156.40   19.39  23.96
Exposure cessation group
QUIT      49.6 (71/143)
PERSIST      50.3 (72/143)
QUIT = quit smoking in Trimester 1 or 2 and remained smoke-free throughout delivery
PERSIST = smoked throughout pregnancy in all three trimesters
*  p < .05 ;  **  p < .01 ;  ***  p < .001
Table 3. Infant Variables and Physical Growth Parameter Outcomes by Tobacco Exposure Group
                                                                                                                   t test                                 Tobacco exposed                           Nonexposed
Neonate variable                                                                               t             (df)                      M               SD            %               M              SD               %
Length of hospitalization (days)  –0.53  (301)  2.3  1.1   2.2  1.2
Gestational age (weeks)  0.67  (302)  39.04  1.20   39.13  1.17
5-min Apgar  0.66  (301)  8.78  0.73   8.83  0.57
Birth weight (g)  –0.15  (301)  3,428  438   3,420  448
Head circumference (cm)  0.70  (299)  34.2  1.5   34.3  2.1
Length (cm)  0.16  (299)  50.7  2.2   50.7  2.6
Resuscitated with oxygen      47    43
Sex (female)      49    50
Race/ethnicity
White      63    58
African American      22    26
Hispanic      11    12
Asian      1    1
Native American      1    2
Other      1    1
*  p < .05 ;  **  p < .01 ;  ***  p < .001.
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The NTA is designed to be conducted from the initiation of 
feeding during the interval prior to the next feeding (approxi-
mately 3 to 4 hr, depending on feeding schedule), thereby uti-
lizing the neonate’s natural sleep, wake, alertness, and irritabil-
ity patterns. More details concerning administration procedures 
are provided in Riese (1982, 1986, 1987). Briefly, neonatal tem-
perament and behavior in response to feeding, routine han-
dling, auditory and visual stimulation, stressors (a cold disc ap-
plied to the neonate’s thigh, aversive stimuli that elicit reflexes), 
and interventions (pacifier, examiner talking, swaddling, pick-
ing up) are recorded, including the degree of motor activity, 
and the level and quality of alertness and orientation. The states 
in which to present different stimuli to the neonates are speci-
fied in Riese (1987) and were followed accordingly, with the use 
of traditional management methods to facilitate acceptable state 
for each item and module. Assessments were conducted ap-
proximately 45 min after last feeding in a quiet, dimly lit area in 
the room. The examiner first recorded the neonate’s length and 
weight and rated the neonate’s state on a 6-point scale (1 = quiet 
sleep; 2 = active sleep; 3 = drowsy; 4 = alert inactivity; 5 = waking ac-
tivity; 6 = crying). Next, we administered four modules of the 
NTA: attention/ orientation, cold disc stressor, pacifier with-
drawal, and soothing maneuvers. 
The attention/orientation module was administered when 
the neonate was awake and not irritable. During administra-
tion, the neonate’s responses to auditory and visual stimuli 
and to reflex maneuvers were scored, and summary ratings 
of responsiveness and neonate’s reinforcement value were re-
corded. Auditory stimuli, such as a bell, a rattle, or the exam-
iner’s voice, were presented at the right and left sides of the 
neonate three times each for each stimulus, for a total of 18 tri-
als. Each auditory trial was scored on a 4-point scale (1 = no 
orienting response; 4 = a strong orienting response with eyes search-
ing and head turning toward the sound). For visual stimuli (e.g., 
bulls-eye, examiner’s face), the stimulus was positioned first 
at the center of the visual field, then moved around the neo-
nate’s head to the right or to the left at a 90° angle, back to 
the center, around the other side at a 90° angle, and then back 
to the center. Each visual item first moved to the right or to 
the left twice, for a total of four trials with each item. Visual 
items were scored on a 4-point scale (1 = no following response; 
4 = sustained fixation and following with eyes and head). Ocular re-
flexes, optic and acoustic blinks, and rotation were adminis-
tered, as well as elicitation of rooting, sucking, withdrawal to 
toothpick prick, and Moro reflexes. Although these items were 
scored on a 3- or 4-point scale, such reflex testing typically re-
sults in little variability in healthy full-term neonates. There-
fore, in response to these maneuvers, the latency to cry was 
recorded and the degree of irritability was rated on a 5-point 
scale (1 = not irritable; 5 = highly irritable). Finally, the exam-
iner made summary ratings of the neonate’s general appear-
ance and alertness (1 = poor; 5 = excellent), cuddliness (1 = re-
sists and/or thrashes and/or stiffens; 5 = always molds, relaxes and 
clings), responsiveness to the different stimuli (1 = not irritable; 
5 = highly irritable), consolability (1 = never irritable; 5 = uncon-
solable), reinforcement value of the neonate to the examiner (1 
= glad to be finished; 5 = fun to have at home), and predominant 
state throughout the module. 
The cold disc stressor module was administered when the 
neonate was quiescent and not irritable. This module con-
sisted of five trials in which a metal disc cooled by immersion 
in ice water was held against the quiescent neonate’s thigh for 
5 s. The neonate’s latency to irritability (in seconds), rated irri-
tability during and after presentation of the stimulus, duration 
of soothing if required (in seconds), and total latency to soothe 
(in seconds) were recorded. Trials were presented at least 60 s 
apart, and the intertrial interval was lengthened if necessary 
to soothe the neonate. If the neonate was not soothed after 3 
min, subsequent trials were discontinued. An overall sum-
mary rating (1 = not irritable to cold disc; 6 = unconsolable) also 
was scored at the conclusion of the module. 
The pacifier withdrawal module was administered when 
the neonate reached a moderate level of irritability, with fuss-
iness and intermittent cry vocalizations. After the examiner 
noted the degree of irritability, a pacifier was given to the cry-
ing neonate. The latencies to suck and to console (in seconds) 
were recorded. After 30 s, the examiner removed the pacifier 
while the neonate was still sucking and again recorded the la-
tency to cry, behavioral state, and posttrial irritability level (1 
= not irritable, or no soothing needed; 5 = could not console with 
pacifier in 3 min). Up to five pacifier withdrawal trials were ad-
ministered. Trials were terminated if the neonate did not be-
come irritable after 3 min. An overall summary rating (1 = not 
irritable, or no soothing needed to pacifier withdrawal; 5 = could not 
console with pacifier in 3 min on any trial) was made at the con-
clusion of the module. 
Table 4. Intercorrelations of Self-Reported Smoking and Maternal Urine/Infant Meconium Cotinine Value
Variable  1  2  3  4  5  6  7  8  9  10  11  12
1. No. cigarettes per day during first trimester  —  .84**  .79**  .83**  .78**  .76**  .69**  .62**  .51**   .34**  .16*  .04
2. No. cigarettes per day during second trimester   —  .96**  .89**  .96**  .93**  .65**  .66**  .59**  .36**  .27**  .03
3. No. cigarettes per day during third trimester    —  .87**  .94**  .96**  .68**  .65**  .60**  .34**  .29**  .03
4. No. cigarettes per day in week prior to 16-week interview    —  .84** .83** .65**  .91**  .63**  .48** .34**  .19*
5. No. cigarettes per day in week prior to 28-week interview     —  .91**  .68**  .63**  .58**  .30**  .23**  .02
6. No. cigarettes per day in week prior to delivery interview      —  .58**  .60**  .62**  .32**  .36**  .03
7. Urine cotinine (ng/ml) at 16-week interview        —  .83**  .77**  .46**  .05  .17**
8. Urine cotinine (ng/ml) at 28-week interview         —  .59**  .30**  .12  .00
9. Urine cotinine (ng/ml) at delivery          —  .38**  .25**  .05
10. Infant meconium cotinine level (ng/g)           —  .03  .02
11. Infant urine cotinine at 2-week assessment            —  .17*
12. Infant urine cotinine at 4-week assessment             —
*  p < .05 ;  **  p < .001
8 Es p y E t al i n Deve l o pm en ta l ps y c hol og y  (2010) 
The soothing maneuvers module also was administered 
when the neonate was at a moderate level of irritability. Tri-
als consisted of graded items designed to foster soothing and 
were presented in the following order: soothingly talking to the 
neonate, soothing talking plus patting the neonate’s stomach, 
putting the neonate in the prone position, lifting the neonate to 
the shoulder, swaddling the neonate, and cradling the swad-
dled neonate horizontally. Before each trial, the examiner rated 
the degree of irritability, whereas after each trial, the examiner 
rated degree of soothability. At the end of the module, the ex-
aminer made an overall summary rating (1 = no soothing needed; 
5 = not soothed by any technique). When the NTA was concluded, 
the examiner scored the neonate’s final behavior state. 
Other potential influences on neonatal self-regulation. 
Smoking during pregnancy is related to maternal and neona-
tal risk factors—such as lower maternal education, depression, 
psychopathology symptoms (e.g., Baghurst, Tong, Wood-
ward, & McMichael, 1992; Schuetze & Eiden, 2006; Wakschlag, 
Pickett, et al., 2002), maternal health, and perinatal complica-
tions—which are associated with adverse developmental out-
comes independent of exposure (e.g., Eyler & Behnke, 1999; 
Schuetze & Eiden, 2007; Schuetze, Eiden, & Dombkowski, 
2006). During all study sessions, women completed ques-
tionnaires and study instruments, including a brief psychiat-
ric symptom screening (Brief Symptom Inventory; Derogatis, 
1975), the Conners Adult ADHD Rating Scale: Short (Con-
ners, Erhardt, & Sparrow, 1998), and the Woodcock–Johnson 
Brief Intellectual Ability assessment (Woodcock, McGrew & 
Mather, 2001). Standardized scores derived from instrument 
normative tables were used in the analyses. 
Analysis 
Creating factor scores. Unlike in previous studies with the 
NTA, we elected to pool and reduce the dependent variables 
into meaningful constructs to enhance reliability using princi-
pal axis factor analysis with oblique (promax) rotation. Those 
items (largely the reflex items) with communalities of less than 
0.35 were eliminated because of unreliability (Gorsuch, 1983). 
As recommended by Gorsuch (1983), we examined eigenval-
ues (>1), scree plots, and the percentage of variance explained 
(>10%) to select the number of factors to retain. Results indi-
cated that a three-factor solution best fit the data. The factor 
pattern matrix is shown in Table 5. Factor 1 was labeled Irrita-
ble Reactivity, as it was composed largely of the neonate’s irri-
table reaction to the auditory and visual stimuli and to routine 
handling as a part of reflex elicitation and maneuvers. Factor 
2, composed of the neonate’s orientation and attention to au-
ditory and visual stimuli, was labeled Attention. Finally, the 
items that involved reactions to the cold disc, pacifier, and 
soothing maneuvers, as well as behavior prior to the next 
feeding, loaded on the third factor, labeled Stressor Dysregu-
lation. The average factor intercorrelations were as follows: for 
Irritable Reactivity and Attention, r = –.20; for Irritable Reac-
tivity and Stress Dysregulation, r = .46; and for Attention and 
Stress Dysregulation, r = .11. The three computed factor scores 
for each participant at each time point were used as the depen-
dent variables, and the means and standard errors of each fac-
tor by exposure group are plotted in Figure 1a. 
Developing the baseline growth model. To evaluate the 
impact of prenatal tobacco exposure on the development of 
neonatal regulation, we used hierarchical linear models to 
model change across the three time points, with a separate 
model for each regulatory factor. Hierarchical linear modeling 
takes advantage of the increased reliability of change assess-
ments when data are collected at more than two time points to 
characterize developmental processes and deviations. The first 
analytic step was to determine the baseline growth model de-
rived from the unconditional model that included only a per-
son-level variance term (i.e., a random intercept). Before any 
modifications were made to the structure of either age or the 
variance components in the model, gestational age was intro-
duced as a covariate in each model because of its known im-
Table 5. Neonatal Temperament Assessment Factor Structure and Observed Interfactor Correlations
                                                                                                                                                                     Factor loading
Neonatal temperament assessment item                     Irritable reactivity                                              Attention                                  Stress dysregulation
Irritability before feeding  0.40  0.06  0.81
Irritability to visual stimuli  0.88  –0.12  0.43
Irritability to auditory stimuli  0.80  –0.19  0.37
Irritability to handling  0.89  –0.11  0.44
Irritability to reflex elicitation  0.89  –0.06  0.41
Latency to soothe after Moro reflex  0.70  –0.02  0.40
Soothability after reflex elicitation  0.85  –0.11  0.40
Mean visual following—bull’s-eye  –0.18 0.67  0.05
Mean auditory orienting—rattle  –0.07  0.87  0.10
Mean auditory orienting—bell  –0.04  0.87  0.10
Mean auditory orienting—voice  –0.14  0.90  0.12
Mean visual following—face and voice  –0.09  0.61  0.10
Overall alertness summary  –0.19  0.87  0.08
Cold disc stressor summary  0.47  0.09  0.65
Pacifier withdrawal summary  0.41  0.13  0.81
Soothing maneuvers summary  0.41  0.07  0.89
Rated reinforcement value  –0.67  0.34  –0.32
Significant factor loadings (above 0.60 or below –0.60) are presented in boldface.
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pact on neonatal neurobehavior (e.g., Korner, Brown, Dimi-
celi, & Forrest, 1989; Riese et al., 1985). Gestational age was a 
significant predictor of each of the dependent variables in the 
linear growth models of age: for Attention, t(300) _ 3.61, p _ 
.001; for Irritable Reactivity, t(304) = 2.72, p < .01; and for Stress 
Dysregulation, t(304) = 2.26, p < .03. Therefore, we retained 
this variable as a covariate in all models. Recruitment site was 
included in all models as a covariate to control for any spuri-
ous site-specific variance. 
Visual inspection of spaghetti plots of individual factor 
scores across the three observations suggested that modeling 
age as a quadratic process might be most appropriate to de-
scribe growth in the Irritable Reactivity and Stress Dysregu-
lation constructs. Although Attention growth appeared lin-
ear, fit of the quadratic term was evaluated for consistency. 
In these analyses, age was centered at 0.2 weeks, and each 
of the three factor scores was then fitted as functions of lin-
ear and quadratic (centered) age. The coefficient for the qua-
dratic term did not differ from zero for Attention, t(676) = 
–0.17, p > .86, but differed from zero for both Irritable Re-
activity, t(675) = –6.49, p < .0001, and Stress Dysregulation, 
t(683) = –7.64, p < .0001. 
Next, we considered deviations in modeling the person-
level covariance structure, where the coefficient of the age 
term was allowed to vary in each of the models. For the linear 
model of Attention, model fit comparisons indicated that the 
random-intercept-only model was preferred (Akaike informa-
tion criterion [AIC] of 2,423.1 vs. 2,424.4 for the random inter-
cept-and-slope model; Bayesian information criterion [BIC] of 
2,430.5 vs. 2,439.3 for the random intercept-and-slope model). 
For Irritable Reactivity, the model allowing for both random 
intercept and slope terms improved model fit when both 
AIC values (2,404.8 vs. 2,435.2 for the random-intercept-only 
model) and BIC values (2,412.2 vs. 2,442.6) were considered. 
A fairly wide range of quadratic trends were also exhibited 
in the individual plots for Irritable Reactivity. Thus, models 
were fitted where the (centered) age and quadratic age terms 
were allowed to vary across neonates in separate models. Like 
Stress Dysregulation, the growth model that included random 
intercept and slope terms significantly improved model fit 
over the random-intercept-only model when AIC values alone 
were considered (2,260.7 vs. 2,267.7 for the random intercept 
only) but not when considering BIC (2,275.6 vs. 2,275.2). The 
final baseline model for Attention, then, was linear in age, 
with only the intercept as a random coefficient, whereas for 
Irritable Reactivity and Stress Dysregulation, linear and qua-
dratic changes in age were modeled, with only the intercepts 
allowed to vary randomly among neonates. 
Modeling the impact of exposure. Exposure-related pre-
dictors were considered in separate models and included 
exposure group (tobacco exposed vs. nonexposed); expo-
sure-cessation group: QUIT (stopped smoking during preg-
nancy during the first or second trimester and remained quit 
throughout the third trimester) versus PERSIST (smoked 
throughout pregnancy); average self-reported smoking for 
each trimester (cigarettes/day); average self-reported smoking 
Figure 1. Growth in attention, irritable reactivity, and stress dysregulation factor scores in neonates. (a) Tobacco-exposed and nonexposed neo-
nates; (b) tobacco-exposed neonates whose mothers quit in the first or second trimester, those who persisted, and nonexposed neonates.
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at the 16-, 28-, and 40-week interviews (cigarettes/day); ma-
ternal urinary cotinine level at the 16-, 28-, or 40-week inter-
views (scaled in units of 100 ng/mL); and neonate meconium 
cotinine level (scaled in units of 100 ng/g). To characterize the 
impact of exposure on physical growth, we conducted t tests 
where the exposure variable was categorical and regressions 
were used for continuously distributed exposure variables. 
For the hierarchical growth models, we developed conditional 
models to test the hypotheses including the effect of the ex-
posure-related predictor on both the intercept and growth pa-
rameters. We conducted the analyses, centering at 0.2, 2, and 
4 weeks, respectively, in order to characterize the relation to 
neonatal behavior at each time point. We entered each ex-
posure-independent variable as a predictor of the pattern of 
growth (intercept, linear change, quadratic acceleration) and 
then used a backwards trimming procedure to select the best 
fitting conditional model, deleting those when not significant 
for the higher growth term and then working progressively 
backwards through the growth terms. We scaled the continu-
ous predictors so that the estimated parameter represented the 
incremental change in the dependent variable that was associ-
ated with each additional cigarette smoked or each additional 
100 cotinine units at that interview. 
Selection of covariates. We considered a range of covari-
ates for inclusion: marital status, maternal education, family 
income, mother’s age at delivery, average number of alcoholic 
drinks per day during the first trimester, Medicaid status, ne-
onate sex, neonate and mother’s race/ethnicity (White vs. 
non-White), neonate environmental tobacco exposure (as 
measured by cotinine in neonate urine collected at the 2- and 
the 4-week assessments), maternal prescription medication 
use (antidepressant, pain, or asthma medication, each coded 
as 0 = absent; 1 = present), gravida, parity, weight gain, mother 
health and delivery variables (diabetes, heart disease, placen-
tal abruption, thyroid, anemia, hypertension/pre-eclampsia, 
infection, delivery type [vaginal vs. cesarean/other] with the 
same 0,1 coding), Brief Symptom Inventory summary index, 
Attention Deficit/Hyperactivity Disorder index of the Con-
ners Adult ADHD Rating Scale: Short, and the Woodcock–
Johnson Brief Intellectual Ability assessment overall IQ es-
timate. Covariates were analyzed separately and selected 
according to the methods of J. L. Jacobson and Jacobson (1996) 
to control the influence of variables that co-occur with prena-
tal smoking without inappropriately reducing exposure-re-
lated variance. If the correlation of the covariate with both ex-
posure status (nonexposed vs. tobacco exposed) and the NTA 
factor score differed from zero at the p < .10 level, the covari-
ate was included in the models. 
For Attention, mother’s age at delivery, maternal educa-
tion, and the maternal IQ estimate were retained for consid-
eration as covariates through these methods. All three can-
didate covariates were added to the baseline model, and a 
backwards stepwise procedure was used to determine which 
among them was to be retained in the final model. Mother’s 
age was removed first from the model, t(292) = 0.12, p > .90, 
followed by education, t(291) = 0.58, p > .55. The remaining co-
variate—mothers’ IQ estimate—t(291) = 3.33, p = .001, was re-
tained. None of the aforementioned covariates met the crite-
ria for model inclusion for either Irritable Reactivity or Stress 
Dysregulation. 
Results
Physical growth indices at birth as a function of exposure 
group status are shown in Table 3. Tobacco-exposed and non-
exposed groups did not differ in birth weight, t(301) _ _0.15, 
p _ .88; head circumference, t(299) = 0.70, p > .48; or length, 
t(299) = 0.16, p > .87. Within the exposed neonates, there 
were no differences in these physical growth indices in those 
born to women who quit during the first or second trimester 
(QUIT) and those whose smoking persisted throughout preg-
nancy (PERSIST; all ps > .47). Table 6 contains the results of re-
gression models with the self-reported smoking and biospec-
imen predictors. Despite the lack of overall exposure group 
differences in birth weight, a dose– response relation was ev-
ident. Each additional cigarette smoked in the third trimester 
as reported by the mother was associated with an 11.55-g dec-
rement in birth weight. A similar trend was observed for the 
Table 6. Exposure-Related Predictors and Impact on the Neonatal Physical Growth Measured at Birth
                                                                                                                                                      Physical growth measured at birth
                                                                                                                                  Birth weight              Head circumference              Body length
Exposure predictor                                                                                            b           SE            β           b           SE           β            b            SE            β
Maternal self-reported average smoking (no. of cigarettes/day)
Trimester 1  –2.49  5.37  –0.03  –0.01  0.02  –0.03  –0.02  0.03  –0.05
    16-week interview  –6.70  6.77  –0.07  –0.01  0.03  –0.02  –0.05  0.04  –0.10
Trimester 2  –10.41†  5.46  –0.11†  –0.03  0.02  –0.06  –0.04  0.03  –0.08
    28-week interview  –11.56*  5.47  –0.12*  –0.03  0.02  –0.06  –0.05  0.03  –0.09
Trimester 3  –11.55*  5.54  –0.12*  –0.03  0.02  –0.07  –0.05  0.03  –0.10
    40-week interview  –14.55*  5.69  –0.15*  –0.04†  0.02  –0.98†  –0.05  0.03  –0.09
Cotinine level (100 ng/ml, ng/g)
16-week maternal urine ****  –17.24*  7.85  –0.16*  –0.04  0.04  –0.09  –0.09*  0.04  –0.15*
28-week maternal urine ****  –9.88  6.06  –0.09  –0.03  0.03  –0.07  –0.01†  0.03  –0.10†
    At delivery maternal urine ****  –46.78  18.32  –0.15*  –0.07  0.08  –0.05  –0.30**  0.10  –0.18**
    At delivery infant meconium **  –0.05  4.91 <–0.01  –0.01  0.02  –0.02  0.02  0.03  0.04
b = unstandardized beta weight; SE = standard error;   β = standardized beta weight.
†  p < .10 ;  *  p < .05 ;  **  p < .01
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number of cigarettes reported for the second trimester. The av-
erage number of cigarettes smoked per day in the week prior 
to both the 28- and 40-week interviews was associated with a 
respective birth weight decrement of 11.56 and 14.55 g, respec-
tively. Furthermore, cotinine in maternal urine at both the 16- 
and 40- week interviews predicted birth weight, with a respec-
tive difference of –17.24 and –46.78 per 100 ng/ml cotinine. 
For body length, a similar dose–response pattern was evident, 
where the maternal urine cotinine levels at 16 and 40 weeks 
predicted decrements in body length at birth. Marginal trends 
were observed for the maternal urinary cotinine values at the 
16-, 28-, and 40-week interviews. The magnitude of these ef-
fects was similar. Neither self-reported smoking nor biospeci-
men results predicted head circumference. 
The estimated intercept and linear growth (if applicable) 
parameter values associated with the exposure predictors 
for the hierarchical growth models for the Irritable Reactiv-
ity, Attention, and Stress Dysregulation factor scores are pre-
sented in Table 7. Tobacco-exposed and nonexposed neonates 
differed in Attention factor score obtained shortly after birth 
and in the rate of growth. The pattern of Attention growth is 
shown in Figure 1a. Tobacco-exposed neonates had, on aver-
age, lower Attention scores by 0.32 at two days after birth than 
did nonexposed neonates, t(765) = –3.23, p < 0.01. The signif-
icantly higher rate of growth (γ = 0.10) evidenced among to-
bacco-exposed neonates, t(609) = 2.88, p < .01, resulted in a di-
minishing difference in Attention score means between the 
two groups at the 2-week time point of 0.14, t(299) = –2.01, p 
< .05, and comparable Attention scores between the groups at 
the 4-week assessment, t(692) = 0.60, p > .55. 
Among tobacco-exposed neonates, the PERSIST and QUIT 
groups demonstrated different Attention factor scores shortly 
after birth and different rates of growth of these scores. The 
PERSIST group had, on average, lower Attention scores by 
0.40 at two days after birth as compared with nonexposed ne-
onates, t(762) = –3.266, p < 0.01, and the difference of 0.24 be-
tween the QUIT and nonexposed groups was also significant, 
t(766) = –1.98, p < .05. The significantly higher rate of growth 
(γ = 0.126) evidenced among PERSIST neonates, t(605) = 2.94, 
p < .01, resulted in a diminishing difference in Attention score 
means of 0.175 between the PERSIST and nonexposed groups 
at age 2 weeks, t(298) = –1.98, p < .05, and comparable Atten-
tion scores between the groups at the 4-week evaluation, t(699) 
= 0.67, p > .50. The QUIT group demonstrated a higher, but 
nonsignificant, rate of growth (γ = 0.072), t(609) = 1.71, p > .08 
compared with the nonexposed group. Growth trajectories are 
shown in Figure 1b. 
Self-reported average number of cigarettes smoked per 
day during the first trimester was related to the pattern of 
Attention growth in a dose-dependent fashion, with each cig-
arette smoked associated with a 0.034-reduction in Attention 
score at 0.2 weeks, t(775) = –3.22, p < .01, and with a faster 
rate of change of 0.012 in Attention score, t(606) = 3.15, p < 
.01, across the neonatal period. A similar pattern was ob-
served for self-reported smoking during the second trimes-
ter and the average number of cigarettes smoked per day re-
ported in the week prior to the 28-week interview, with each 
cigarette smoked associated with a 0.047 and a 0.042 reduc-
tion, respectively, in Attention score at 0.2 weeks, t(779) = 
–4.03, p < .0001, t(784) = –3.72, p < .001, and with a faster rate 
of Attention score change of 0.014 and 0.011, t(607) = 3.36, p < 
.0001, t(602) = 2.69, p < .006, across the neonatal period. Av-
erage self-reported smoking during the third trimester and in 
the week prior to the 40-week interview also was related neg-
atively to the Attention factor score, where each reported cig-
arette smoked per day was related to a 0.045 and 0.044 At-
tention score reduction, respectively, at 0.2 weeks, t(782) = 
–3.74, p < .001, and t(771) = –3.43, p < .001, and was also asso-
ciated with a 0.012 and 0.011 higher rate of change in Atten-
tion score, t(608) = 2.94, p < .01; t(600) = 2.45, p < .02. Cotinine 
levels in maternal urine collected at 28 weeks and at delivery 
were related to the pattern of growth in Attention scores such 
that greater assayed cotinine levels were associated with a re-
duction in Attention scores of 0.023 and 0.087 at 0.2 weeks, 
respectively, t(771) = –2.00, p < .05, t(737) = –2.35, p < .02, and 
with a marginally faster rate of change of 0.021 in Attention 
scores (γ = 0.021), t(579) = 1.69, p < .10. At 2 weeks of age, 
neonatal Attention scores were related negatively to average 
self-reported smoking during the second, t(305) = –2.74, p < 
.01, and third, t(306) = –2.71, p < .01, trimesters and smok-
ing in the week prior to the 28-week, t(305) = –2.93, p < .01, 
and 40-week, t(304) = –2.71, p < .01, interviews and was asso-
ciated marginally with self-reported smoking in the first tri-
mester, t(307) = –1.78, p < .10, and with maternal urine coti-
nine level at delivery, t(291) = –1.89, p < .10. All self-reported 
smoking and cotinine levels were not related to Attention 
score level at neonates’ 4 weeks of age ( ps > .30). 
The group-related pattern of Irritable Reactivity growth 
is shown in Figure 1a. Unlike Attention, growth patterns did 
not differ significantly by exposure group classification at 0.2 
weeks, t(831) = 0.36, p > .72, or 2 weeks, t(752) = 1.52, p > 
.12. The tobacco-exposed group was consistently more irri-
table (difference in intercepts between tobacco-exposed and 
nonexposed groups of 0.039) across the neonatal period and 
reached marginal significance at 4 weeks of age (γ = 0.158), 
t(684) = 1.67, p < .10. Similarly, no differences were noted be-
tween the nonexposed group and either of the exposure ces-
sation groups: QUIT, t(827) = 0.86, p > .39, or PERSIST, t(832) 
= –0.33, p > .74, at 0.2 weeks, respectively. There were mar-
ginally significant Irritable Reactivity score differences be-
tween PERSIST and nonexposed participants at 2 weeks (γ 
= 0.214), t(769) = 1.67, p < .10. Average self-reported smok-
ing in each trimester or at each interview was not related to 
any Irritable Reactivity growth parameters, nor were mater-
nal urine or meconium cotinine levels related to this factor at 
any time point. 
Like Irritable Reactivity, Stress Dysregulation scores did 
not differ by exposure group classification, t(841) = –0.26, p > 
.79, nor were there any differences between the nonexposed 
group and either the QUIT or the PERSIST group, t(836) = 
–0.61, p > .54, and t(841) = 0.13, p > .89, respectively. For Stress 
Dysregulation, the variables of self-reported smoking at each 
interview, cotinine levels in maternal urine, and cotinine lev-
els in neonatal meconium were unrelated to growth in Stress 
Dysregulation scores or to Stress Dysregulation scores at 0.2, 
2, or 4 weeks of age. Self-reported smoking during the first 
trimester was related marginally to quadratic growth (γ = 
–0.005), t(665) = –1.79, p < .08, but not to Stress Dysregulation 
scores at any age, and average self-reported smoking in sec-
ond and third trimesters was not related to any Stress Dysreg-
ulation growth parameters over the course of neonates’ first 
month of life.
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Table 7. Exposure-Related Predictors and Impact on Neonatal Self-Regulation, Attention/Orientation, Irritable Reactivity, and 
Stressor Dysregulation Growth Parameters
                                                                                                                                                         0.2 Weeks                    2 Weeks                    4 Weeks
Variable                                                                                             Quadratic     Slope     Intercept       SE        Intercept       SE        Intercept        SE
Attention/orientation
Tobacco-exposed/nonexposed group status   0.098**  –0.318**  0.010  –0.141*  0.070  0.055  0.092
Exposure-cessation group
PERSIST   0.126**  –0.402**  0.123  –0.175*  0.088  0.078  0.116
QUIT   0.072†  –0.240*  0.121  –0.110  0.086  0.034  0.113
Maternal self-reported average smoking (no. cigarettes/day)
Trimester 1   0.012**  –0.034**  0.011  –0.014†  0.008  0.010  0.010
    16-week interview   0.005  –0.012  0.014  –0.002  0.010  0.008  0.014
Trimester 2   0.014***  –0.047***  0.012  –0.023**  0.008  0.004  0.011
    28-week interview   0.011**  –0.042***  0.011  –0.023**  0.008  –0.002  0.010
Trimester 3   0.012**  –0.045***  0.012  –0.023**  0.008  0.001  0.011
    40-week interview   0.011*  –0.044***  0.013  –0.025**  0.009  –0.003  0.012
    16-week maternal urine   0.004  –0.015  0.015  –0.009  0.011  –0.001  0.014
    28-week maternal urine   0.007  –0.023*  0.012  –0.011  0.008  0.002  0.011
        At delivery maternal urine   0.021†  –0.087*  0.036  –0.050†  0.026  –0.009  0.033
        At delivery infant meconium   0.003  –0.016†  0.009  –0.010  0.007  –0.004  0.008
Irritable reactivity
Tobacco-exposed/nonexposed group status  –0.016  0.094  0.039  0.107  0.155  0.102  0.158†  0.094
Exposure-cessation group
PERSIST  –0.047  0.229  –0.045  0.135  0.214†  0.128  0.143  0.119
QUIT  0.008  –0.018  0.113  0.132  0.106  0.126  0.158  0.116
Maternal self-reported average smoking (no. of cigarettes/day)
Trimester 1  –0.003  0.016  0.000  0.012  0.017  0.011  0.009  0.010
    16-week interview  0.003  –0.004  –0.011  0.015  –0.009  0.014  0.013  0.014
Trimester 2  –0.003  0.012  0.000  0.012  0.013  0.011  0.007  0.010
    28-week interview  –0.001  0.009  –0.001  0.012  0.011  0.011  0.015  0.010
Trimester 3  –0.002  0.008  0.003  0.012  0.012  0.011  0.010  0.011
    40-week interview  –0.002  0.009  0.003  0.013  0.014  0.011  0.011  0.011
Cotinine level (100 ng/ml, ng/g)
16-week maternal urine  –0.002  0.021  –0.018  0.017  0.014  0.016  0.037  0.015
28-week maternal urine  –0.005  0.023  –0.011  0.013  0.015  0.012  0.009  0.012
    At delivery maternal urine  –0.005  0.030  –0.012  0.039  0.026  0.038  0.032  0.034
    At delivery infant meconium  –0.002  0.006  0.016  0.011  0.021  0.010  0.010  0.009
Stressor dysregulation
Exposure-cessation group
PERSIST  –0.050  0.144  0.016  0.123  0.112  0.117  –0.162  0.109
QUIT  –0.021  0.113  –0.073  0.121  0.062  0.115  0.052  0.106
Maternal self-reported average smoking (no. of cigarettes/day)
Trimester 1  –0.005†  0.017  –0.003  0.011  0.012  0.010  –0.008  0.009
    16-week interview  0.003  –0.016  0.007  0.014  –0.014  0.013  –0.016  0.013
Trimester 2  –0.004  0.011  –0.002  0.011  0.006  0.010  –0.014  0.010
    28-week interview  –0.003  0.007  0.004  0.011  0.006  0.010  0.013  0.012
Trimester 3  –0.003  0.007  0.001  0.011  0.006  0.010  –0.008  0.010
    40-week interview  –0.003  0.010  –0.000  0.012  0.007  0.010  –0.008  0.010
Cotinine level (100 ng/ml, ng/g) 
16-week maternal urine  –0.003  0.009  0.017  0.015  0.022  0.015  0.004  0.014
28-week maternal urine  –0.007  0.026  –0.007  0.012  0.018  0.011  –0.004  0.011
    At delivery maternal urine  –0.004  –0.003  0.038  0.036  0.020  0.034  –0.027  0.031
    At delivery infant meconium  –0.001  0.003  0.005  0.010  0.005  0.009  –0.005  0.008
Covariates for the attention/orientation model are gestational age, site, and the estimated maternal overall intelligence score, and covariates for the 
irritable reactivity and stressor dysregulation models are gestational age and site. QUIT = quit smoking in Trimester 1 or 2 and remained smoke-
free throughout delivery; PERSIST = smoked throughout pregnancy in all three trimesters.
† p  <  .10 ;   *  p < .05 ;  **  p < .01 ;  ***  p < .001
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Discussion
The impact of prenatal tobacco exposure on the early de-
velopment of emergent self-regulatory processes and on phys-
ical growth at birth was assessed with a prospective design, 
indexing exposure through self-report and bioassays collected 
at several time points during pregnancy. Neonatal self-reg-
ulatory behaviors for modulating attention, irritability, and 
response to stressors were assessed three times in the first 
month of life and empirically parsed into meaningful con-
structs, enabling characterization of the dynamic impact of 
prenatal tobacco exposure on the trajectories of change in light 
of substantial growth and instability in this very early period 
(Korner, Kraemer, Reade, Forrest, & Dimiceli, 1987). This fine-
grained analytic strategy enabled a number of new insights 
into the effects of exposure on the very early development of 
self-regulatory behaviors in several domains. 
Although the prevalence, amount, and persistence of smok-
ing in pregnant women today differs from that in previous de-
cades, the oft-reported continuous dose–response relation be-
tween pregnancy smoking and birth weight was evident here. 
Heavier and more persistent smoking across pregnancy im-
pacted birth weight and body length deleteriously. Self-re-
ported second- and third-trimester smoking, self-reported 
smoking at the 28- and 40-week interviews, and cotinine in 
maternal urine at 16 and 40 weeks, predicted birth-weight dec-
rements. The magnitude of the exposure effect on birth-weight 
effect was largest for these third-trimester smoking predictors 
compared with those measured earlier in pregnancy. Maternal 
urinary cotinine at delivery also was associated with signifi-
cant body length decrements. Marginal trends were observed 
for maternal urine cotinine levels at the 16-, 28-, and 40-week 
interviews. In contrast to these dose–response relations, the 
lack of exposure group differences in these indices of physi-
cal growth at birth is likely a consequence of lower amount of 
tobacco exposure overall compared with cohorts ascertained 
in the 1970s and 1980s, the sample selection methods to min-
imize other influences and exposures, and the greater sensi-
tivity of continuous measures of exposure in comparison with 
gross grouping. Neither exposure-group-level nor dose–re-
sponse differences in head circumference were evident, sug-
gesting that the protective, brain-growth-sparing mechanism 
was not affected by prenatal tobacco exposure, unlike what 
has been observed in prenatally cocaine exposed neonates (Ey-
ler, Behnke, Conlon, Woods, & Wobie, 1998). 
Importantly, the pattern of development of attention skills 
differed among tobacco-exposed and nonexposed neonates 
across the first month of life. Consistent with the stated hy-
potheses, tobacco-exposed neonates showed less orienta-
tion and attentive tracking behaviors to auditory and vi-
sual stimuli. Interestingly, exposure group differences were 
not constant over the first month of life. Differences were 
most evident on the Attention factor scores from the assess-
ment conducted shortly after birth and remained apparent at 
2 weeks of age. By 4 weeks of age, however, Attention scores 
were comparable between the two groups, contrary to predic-
tion. This average trajectory is consistent with a general pat-
tern of developmental catch-up, where the initial reduced 
level of performance in tobacco-exposed neonates was accom-
panied by a more rapid rate of development, resulting in com-
parable skills at the end of the observation period. Further-
more, attention skills scores were lower shortly after birth in 
tobacco-exposed neonates whose mothers smoked more and 
more persistently across pregnancy compared with those who 
quit smoking during or before the second trimester. Of note 
too is the relatively modest change in Attention skills in non-
exposed neonates relative to the fairly steep rate of change for 
tobacco-exposed neonates, which again was greater in those 
who smoked more and more persistently in pregnancy. 
Clearly, early in the neonatal period, attention skills dif-
fered in tobacco-exposed neonates relative to their nonex-
posed peers. What is unclear is whether this difference reflects 
an effect of withdrawal or is a unique exposure-related devel-
opmental vulnerability in this period of rapid change. The dif-
ferences in attention observed shortly after birth are consis-
tent with withdrawal effects, reflecting the residual rebound 
impact of cessation of nicotine exposure that occurs as a con-
sequence of birth. This interpretation is consistent with earlier 
findings where exposure also was measured with self-report 
(e.g., Fried et al., 1987; S. W. Jacobson, 1984; G. A. Richardson 
et al., 1989; Saxton, 1978; Streissguth, Sampson, Barr, Book-
stein, & Carmichael, 1994). These findings are also consis-
tent with those from a more recent study that included bio-
assays of exposure and was specifically designed to examine 
withdrawal in the first days of life (Godding et al., 2004). The 
dose–response relation observed in the present between self-
reported maternal smoking in the third trimester and at the 
delivery interview, as well as cotinine levels in maternal urine 
at delivery and in neonatal meconium, and the level of atten-
tion behavior observed shortly after birth support the with-
drawal interpretation. 
Withdrawal effects from progressive nicotine clearing also 
might contribute to the substantive differences observed in At-
tention scores that persisted at 2 weeks of age. The difference 
in Attention scores between tobacco-exposed and nonexposed 
neonates was substantially smaller (about half in magnitude) 
at 2 weeks of age compared with shortly after birth. Self-re-
ported smoking in the third trimester and at the 40-week inter-
view, as well as cotinine levels in maternal urine at delivery, 
predicted the differences of Attention scores between tobacco-
exposed and nonexposed infants at 2 weeks of age. However, 
cotinine levels in neonatal meconium were not related to at-
tention behaviors at 2 weeks of age, which would have been 
expected if the exposure group differences were due to reced-
ing withdrawal effects. 
Typically, 2 weeks of age is considered beyond the win-
dow when acute withdrawal effects are observed (Stroud, Pas-
ter, Papandonatos, et al., 2009). Unlike Godding et al. (2004), 
women in the present sample reported smoking substantially 
fewer cigarettes per day. The decreased number of cigarettes 
per day across pregnancy results in a much lower dose of nic-
otine to be cleared after birth and thereby might decrease the 
likelihood and severity of withdrawal effects shortly after 
birth and certainly 2 weeks later. In the present study, neo-
nates whose mothers quit smoking during pregnancy showed 
poorer attention and orientation skills shortly after birth com-
pared with those who were nonexposed, which also is not 
consistent with withdrawal effects. Furthermore, the amount 
of smoking reported in the first and second trimesters, as well 
as in the week prior to the 28-week interview, predicted atten-
tion skills at 2 weeks of age, earlier in pregnancy than would 
be a consequence of nicotine clearing. However, the general 
consistency is that smoking across pregnancy, and the resul-
tant substantive correlations between smoking indicators mea-
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sured at different points during pregnancy, makes it difficult 
to attribute independent effects on neurobehavior at each age. 
The observed differences in attention early in the neonatal pe-
riod, however, also are not likely to be due to secondhand to-
bacco exposure, as secondhand smoke exposure was low in 
the neonatal period, confirmed by the low cotinine levels in 
neonate urine and the much smaller relation to prenatal smok-
ing amounts of our present study. 
Although exposure-group-related differences in attention 
were expected at 4 weeks of age, the average trajectories did 
not differ between exposure groups at the end of the neona-
tal period. Neither self-reported smoking nor cotinine levels 
measured in biospecimens were related to exposure group dif-
ferences in Attention scores at 4 weeks of age, consistent with 
results obtained by Yolton et al. (2009). The pattern of skill 
growth for tobacco-exposed neonates was consistent with ini-
tial deficits followed by subsequent “recovery,” where at 4 
weeks of age, all neonates showed comparable attention skills. 
In this period of rapid developmental growth in attention 
skills for all neonates, tobacco-exposed neonates show early 
deficits, as well as faster growth rates, both of which were re-
lated to the degree of exposure. The longitudinal design used 
here disentangled the age-specific exposure effects in the con-
text of the developmental trajectory of skill development. 
Also contrary to hypothesis, exposure-group-level (to-
bacco exposed vs. nonexposed) differences in the Irritable Re-
activity factor scores shortly after birth were not significant; 
nor were there exposure group effects on linear or quadratic 
growth rates. These findings contrast with those from other 
studies that used both self-report (Fried & Makin, 1987; S. W. 
Jacobson, 1984; Nugent, Lester, Greene, & Wieczorek-Deering, 
1996; Picone et al., 1982; Schuetze & Eiden, 2007) and bioas-
says (Godding et al., 2004; Law et al., 2003; Mansi et al., 2007; 
Stroud, Paster, Goodwin, et al., 2009) to index prenatal tobacco 
exposure. What is of interest here is the impact on the devel-
opmental pattern, where the consistent exposure-related dif-
ferences in Irritable Reactivity scores between groups were vi-
sually evident at each age and persistent across the neonatal 
period. The magnitude of the estimated difference in irrita-
ble reactivity between tobacco-exposed and nonexposed neo-
nates was progressively greater across time points, where at 4 
weeks, exposure groups differed marginally. A second look at 
the individual trajectories of Irritable Reactivity scores across 
age suggested a high degree of between-subjects variability in 
exposure-related impacts on Irritable Reactivity scores that is 
superimposed upon a general neonatal increase in irritable re-
activity across the neonatal period. Person-centered methods 
(e.g., Espy, Fang, Charak, Minich & Taylor, 2009) might be ap-
plied fruitfully to identify specific groups of neonates with 
discrepant neonatal developmental patterns related to expo-
sure. Birth is a stressful, energy-demanding event from which 
newborns recover through initial high levels of sleep and low 
irritability (Korner, 1996; Korner, Brown, Reade, & Stevenson, 
1988). Because the Irritable Reactivity factor is composed of 
items that score irritable reactivity to daily living activities—
to handling, physical maneuvers, auditory and visual stimu-
lation—exposure-related irritability would be expected to be 
observed routinely and persistently, at least for a subset who 
are most vulnerable. Given the importance of irritability to so-
licit caregiving, these early, subtle differences perhaps set the 
stage for the ensuing deviations in maternal–infant behavior 
that have been observed (Schuetze & Eiden, 2006, 2007) and 
may be an early precursor to later deviations in emotional dys-
regulatory behavior (Brook et al., 2000; Wakschlag, Leventhal, 
Pine, Pickett, & Carter, 2006). 
Although the self-reported average first-trimester smoking 
was related marginally to a decrease in the rate of deceleration 
in Stressor Dysregulation factor scores, none of the other ex-
posure variables—self-report or biospecimen data—predicted 
differences in the rates of change in, or in the age-specific level 
of, the dysregulation response to midlevel stressors. Dysreg-
ulation behaviors in response to a relatively acute, substan-
tial stressor might be more resilient to the deleterious impact 
of prenatal tobacco exposure, given their deeply rooted, evolu-
tion-selected, adaptive role in signaling immediate discomfort 
and distress. It is important to note, however, that the Irrita-
ble Reactivity and Stress Dysregulation factor scores were re-
lated substantively and, thus, teasing apart the isolated impact 
of exposure on these two dimensions is not a simple endeavor. 
Because tobacco-exposed neonates showed more irritability 
in response to routine handling as shown by the Irritable Re-
activity factor score difference, the introduction of a stressful 
stimulus (e.g., cold disc) might not have provoked as much of 
an increase in negative emotionality as a result of natural con-
straints in the neonatal behavioral repertoire, somewhat akin 
to a ceiling effect. Including stress biomarkers, such as cortisol 
or heart-rate measurements, might reveal latent physiologic 
differences that could help disentangle these two dimensions, 
as these methods have been successful in revealed exposure-
related differences (e.g., Franco, Chabanski, Szilwowski, Dra-
maix, & Kahn, 2000; Schuetze & Eiden, 2006). 
Sampling methods of this study deserve particular com-
ment, particularly in light of the decadal changes in smoking 
behavior, as a contributor to the obtained pattern of findings. 
First, women were recruited prospectively in the first trimes-
ter, and thus it was impossible to balance selection on persis-
tence of smoking throughout pregnancy. Second, our goal was 
to minimize extraneous influences other than smoking; thus, 
nonsmoking women were selected specifically to be more 
comparable demographically to those who smoked, which cer-
tainly resulted in exposure groups that were more similar (al-
though not completely so) than is typically found in commu-
nity-based samples. Consistent with minimizing extraneous 
influences and with our interests in the neurobiologic effects 
of nicotine on the nervous system, our goal was to minimize 
the impact of other exposures, and thus women who reported 
illegal drug use at screening or at interview or who tested pos-
itive in biospecimens, as well as those with known heavy al-
cohol use, were not included in the report here. The benefit of 
this sampling design is its highlighting of the prenatal tobacco 
exposure effects among the background of risks. The down-
side, however, is that there were fewer heavier and more per-
sistent smokers in the present study, as higher alcohol and 
other drug use is substantially more common in women who 
smoke heavily during pregnancy. These sampling differences 
must be evaluated carefully in interpreting the pattern of find-
ings across studies. 
One strength of this effort is the longitudinal design that 
permitted characterization of the impact of prenatal tobacco 
exposure on the development of regulatory skills across the 
first month of life. These findings serve to link those from 
other cross-sectional studies that have focused on withdrawal 
effects, regulatory behavior shortly after birth, and the longer-
term, residual impacts of later exposure at the end of neonatal 
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period. The longitudinal measurement and growth modeling 
strategy takes advantage of the increased reliability of change 
to describe developmental processes and deviations (Rogosa 
& Willett, 1985). The average trajectory was consistent with a 
catch-up pattern for attention skills, consistent with self-right-
ing resilience in development, at least in this sample with rel-
atively low amounts of smoking and less confounding by 
other exposures. The observed trajectory, however, is simply a 
mathematical average, and is superimposed on substantial in-
dividual variation. Of course, the effects observed here in the 
neonatal period are only the first step in establishing the dy-
namic impact of prenatal tobacco exposure on the developing 
nervous system that supports regulatory processes within the 
broader context of parenting and the social environment that 
also interactively shapes development as it unfolds. Whether 
the initial developmental patterns observed in the neonatal 
period are related to disturbances in later attention and emo-
tion regulation behaviors is an important future question, 
as these more basic neonatal skills are integrated into the in-
creasingly complex behavior repertoire of the developing in-
fant and child that are expressed dynamically in varying so-
cial contexts. 
References
Azam, L., Chen, Y., & Leslie, F. M. (2007). Developmental regula-
tion of nicotinic acetylcholine receptors within midbrain dopa-
mine neurons. Neuroscience, 144, 1347–1360. 
Baghurst, P. A., Tong, S. L., Woodward, A., & McMichael, A. J. 
(1992). Effects of maternal smoking upon neuropsychological 
development in early childhood: Importance of taking account 
of social and environmental factors. Paediatric and Perinatal Epi-
demiology, 6, 403–415. 
Bard, K. A., Coles, C. D., Platzman, K. A., & Lynch, M. E. (2000). 
The effects of prenatal drug exposure, term status, and caregiv-
ing on arousal and arousal modulation in 8-week-old infants. 
Developmental Psychobiology, 36, 194–212. 
Bennett, D. S., Mohamed, F. B., Carmody, D. P., Bendersky, M., 
Patel, S., Khorrami, M., & Lewis, M. (2009). Response inhibi-
tion among early adolescents prenatally exposed to tobacco: 
An fMRI study. Neurotoxicology and Teratology, 31, 283–290. 
Brook, J., Brook, D., & Whiteman, M. (2000). The influence of ma-
ternal smoking during pregnancy on the toddler’s negativity. 
Archives of Pediatric and Adolescent Medicine, 154, 381–385. 
Centers for Disease Control. (2008, August). Alcohol terms. 
Retrieved from http://www.cdc.gov/alcohol/terms.
htm#excessive  
Chen, H., Parker, S. L., Matta, S. G., & Sharp, B. M. (2005). Gesta-
tional nicotine exposure reduces nicotinic cholinergic receptor 
(nAChR) expression in dopaminergic brain regions of adoles-
cent rats. European Journal of Neuroscience, 22, 380–388. 
Conners, C. K., Erhardt, D., & Sparrow, E. P. (1998). CAARS—Self-
report: Short Version (CAARS—S:S). North Tonawanda, NY: 
Multi- Health Systems. 
Conter, V., Cortinovis, L., Rogari, P., & Riva, L. (1995). Weight 
growth in infants born to mothers who smoked during preg-
nancy. British Medical Journal, 310, 768–776. 
Day, N., Cornelius, M., Goldschmidt, L., Richardson, G., Robles, 
N., & Taylor, P. (1992). The effects of prenatal tobacco and mar-
ijuana use on offspring growth from birth through 3 years of 
age. Neurotoxicology and Teratology, 14, 407–414. 
Day, N. L., Richardson, G. A., Goldschmidt, L., & Cornelius, M. 
D. (2000). Effects of prenatal tobacco exposure on preschoolers’ 
behavior. Journal of Developmental and Behavioral Pediatrics, 21, 
180–188. 
Derogatis, L. R. (1975). Brief Symptom Inventory. Baltimore, MD: 
Clinical Psychometric Research. 
D’Onofrio, B., Van Hulle, C., Waldman, I., Rodgers, J., Rathouz, 
P., & Lahey, B. (2007). Causal inferences regarding prenatal al-
cohol exposure and childhood externalizing problems. Archives 
of General Psychiatry, 64, 1296–1304. 
Emde, R. N., & Buchsbaum, H. K. (1989). Toward a psychoana-
lytic theory of affect: II. Emotional development and signaling 
in infancy. In S. I. Greenspan & G. H. Pollack (Eds.), The course 
of life: Infancy (pp. 193–227). Madison, CT: International Uni-
versities Press. 
England, L. J., Grauman, A., Qian, C., Wilkins, D. G., Schisterman, 
E. F., Yu, K. F., & Levine, R. J. (2007). Misclassification of ma-
ternal smoking status and its effects on an epidemiologic study 
of pregnancy outcomes. Nicotine Tobacco Research, 9, 1005–1013. 
Espy, K. A., Fang, H., Charak, D., Minich, N., & Taylor, H. G. 
(2009). Growth mixture modeling of academic achievement 
in children of varying birth weight risk. Neuropsychology, 23, 
460–474. 
Espy, K. A., Riese, M. L., & Francis, D. J. (1997). Neurobehavior in 
preterm neonates exposed to cocaine, alcohol, and tobacco. In-
fant Behavior and Development, 20, 297–309. 
Eyler, F. D., & Behnke, M. (1999). Early development of infants ex-
posed to drugs prenatally. Clinical Perinatology, 26, 107–150. 
Eyler, F. D., Behnke, M., Conlon, M., Woods, N. S., & Wobie, K. 
(1998). Birth outcome from a prospective, matched study of 
prenatal crack/ cocaine use: I. Interactive and dose effects on 
health and growth. Pediatrics, 101, 229–237. 
Franco, P., Chabanski, S., Szilwowski, H., Dramaix, M., & Kahn, 
A. (2000). Influence of maternal smoking on autonomic ner-
vous system in healthy infants. Pediatric Research, 47, 215–220. 
Fried, P. A., & Makin, J. E. (1987). Neonatal behavioural correlates of 
prenatal exposure to marijuana, cigarettes and alcohol in a low 
risk population. Journal of Neurotoxicology and Teratology, 9, 1–7. 
Fried, P. A., & Watkinson, B. (2001). Differential effects on facets 
of attention in adolescents prenatally exposed to cigarettes and 
marihuana. Journal of Neurotoxicology and Teratology, 23, 421–430. 
Fried, P. A., Watkinson, B., Dillon, R. F., & Dulberg, C. S. (1987). 
Neonatal neurological status in a low-risk population after pre-
natal exposure to cigarettes, marijuana, and alcohol. Journal of 
Developmental & Behavioral Pediatrics, 8, 318–326. 
Fried, P. A., Watkinson, B., & Gray, R. (1992). A follow-up study 
of attentional behavior in 6-year-old children exposed prena-
tally to marihuana, cigarettes, and alcohol. Journal of Neurotoxi-
cology and Teratology, 14, 299. 
Godding, V., Bonnier, C., Fiasse, L., Michel, M., Longueville, E., 
Lebecque, P., & Galanti, L. (2004). Does in utero exposure to 
heavy maternal smoking induce nicotine withdrawal symp-
toms in neonates? Pediatric Research, 55, 645–651. 
Goldman, P. S. (1974). Plasticity of function in the CNS. In D. G. 
Stein, J. J. Rosen, & N. Butters (Eds.), Plasticity and recovery of 
function in the central nervous system (pp. 149–174). London: Ac-
ademic Press. 
Gorsuch, R. L. (1983). Factor analysis. (2nd ed.). Hillsdale, NJ: 
Erlbaum. 
Hagino, N., & Lee, J. (1985). Effect of maternal nicotine on the de-
velopment of sites for [3H]nicotine binding in the fetal brain. 
International Journal of Developmental Neuroscience, 3, 567–571. 
16 Es p y E t al i n Deve l o pm en ta l ps y c hol og y  (2010) 
Hardy, J., & Mellits, E. (1972). Does maternal smoking dur-
ing pregnancy have a long-term effect on the child? Lancet, 2, 
1332–1336. 
Huizink, A. C., & Mulder, E. J. (2006). Maternal smoking, drink-
ing or cannabis use during pregnancy and neurobehavioral 
and cognitive functioning in human offspring. Neuroscience and 
Biobehavioral Reviews, 30, 24–41. 
Jacobsen, L., Slotkin, T., Westerveld, M., Mencl, W., & Pugh, K. R. 
(2006). Visuospatial memory deficits emerging during nicotine 
withdrawal in adolescents with prenatal exposure to active 
maternal smoking. Neuropsychopharmacology, 31, 1550–1561. 
Jacobson, J. L., & Jacobson, S. W. (1996). Methodological consider-
ations in behavioral toxicology in infants and children. Devel-
opmental Psychology, 32, 390–403. 
Jacobson, S. W. (1984). Neonatal correlates of prenatal exposure to 
smoking, caffeine, and alcohol. Infant Behavior and Development, 
7, 253– 265. 
Johnson, C. H., Vicary, J. R., Heist, C. L., & Corneal, D. A. (2001). 
Moderate alcohol and tobacco use during pregnancy and child 
behavior outcomes. Journal of Primary Prevention, 21, 367–379. 
Kelmanson, I. A., Erman, L. V., & Litvina, S. V. (2002). Maternal 
smoking during pregnancy and behavioural characteristics in 
2-4-month-old infants. Klinische Pädiatrie, 214, 359–364. 
Kopp, C. B. (1982). Antecedents of self-regulation: A developmen-
tal perspective. Developmental Psychology, 18, 199–214. 
Koren, G. (1993). Cocaine and the human fetus: The concept of ter-
atophilia. Journal of Neurotoxicology and Teratology, 15, 301–304; 
discussion, 311–302. 
Korner, A. F. (1996). Reliable individual differences in pre-
term infants’ excitation management. Child Development, 67, 
1793–1805. 
Korner, A. F., Brown, B. W., Dimiceli, S., & Forrest, T. (1989). 
Stable individual differences in developmentally changing 
preterm infants: A replicated study. Child Development, 60, 
502–513. 
Korner, A. F., Brown, B. W., Reade, E. P., & Stevenson, D. K. 
(1988). State behavior of preterm infants as a function of devel-
opment, individual and sex differences. Infant Behavior and De-
velopment, 11, 111–124. 
Korner, A. F., Kraemer, H. C., Reade, E. P., Forrest, T., & Dimi-
celi, S. (1987). A methodological approach to developing an as-
sessment procedure for testing the neurobehavioral maturity 
of preterm infants. Child Development, 58, 1478–1487. 
Kotimaa, A. J., Moilanen, I., Taanila, A., Ebeling, H., Smalley, S. L., 
& Järvelin, S. R. (2003). Maternal smoking and hyperactivity in 
8-year-old children. Journal of the American Academy of Child and 
Adolescent Psychiatry, 42, 826–833. 
Landmesser, L. (1994). Axonal outgrowth and pathfinding. Prog-
ress in Brain Research, 103, 67–73. 
Law, K., Stroud, L., LaGasse, L., Niaura, R., Liu, J., & Lester, B. 
(2003). Smoking during pregnancy and newborn neurobehav-
ior. Pediatrics, 111, 1318–1323. 
Leech, S. L., Richardson, G. A., Goldschmidt, L., & Day, N. L. 
(1999). Prenatal substance exposure: Effects on attention and 
impulsivity of 6-year-olds. Neurotoxicology and Teratology, 21, 
109–118. 
Levin, E. D., & Slotkin, T. A. (1998). Developmental neurotoxicity of 
nicotine. San Diego: Academic Press. 
Lichtensteiger, W., Hefti, F., Felix, D., Huwyler, T., Melamed, E., 
& Schlumpf, M. (1982). Stimulation of nigrostriatal dopamine 
neurones by nicotine. Neuropharmacology, 21, 963–968. 
Linnet, K. M., Dalsgaard, S., Obel, C., Wisborg, K., Henriksen, T. 
B., Rodriguez, A., & Jarvelin, M. R. (2003). Maternal lifestyle 
factors in pregnancy risk of attention deficit hyperactivity dis-
order and associated behaviors: Review of the current evi-
dence. American Journal of Psychiatry, 160, 1028–1040. 
Little, R. J. A., & Rubin, D. B. (2002). Statistical analysis with missing 
data. New York: Wiley. 
Mansi, G., Raimondi, F., Pichini, S., Capasso, L., Sarno, M., Zuc-
caro, P., & Paludetto, R. (2007). Neonatal urinary cotinine cor-
relates with behavioral alterations in newborns prenatally ex-
posed to tobacco smoke. Pediatric Research, 61, 257–261. 
Matheny, A. P., Riese, M. L., & Wilson, R. S. (1985). Rudiments of 
infant temperament: Newborn to 9 months. Developmental Psy-
chology, 21, 486–494. 
Maughan, B., Taylor, A., Caspi, A., & Moffitt, T. E. (2004). Prena-
tal smoking and early childhood conduct problems: Testing 
genetic and environmental explanations of the association. Ar-
chives of General Psychiatry, 61, 836–843. 
McFarland, B. J., Seidler, F. J., & Slotkin, T. A. (1991). Inhibition 
of DNA synthesis in neonatal rat brain regions caused by 
acute nicotine administration. Developmental Brain Research, 58, 
223–229. 
Muneoka, K., Ogawa, T., Kamei, K., Muraoka, S., Tomiyoshi, R., 
Mimura, Y., & Takigawa, M. (1997). Prenatal nicotine exposure 
affects the development of the central serotonergic system as 
well as the dopaminergic system in rat offspring: Involvement 
of route of drug administrations. Developmental Brain Research, 
102, 117–126. 
Navarro, H. A., Seidler, F. J., Whitmore, W. L., & Slotkin, T. A. 
(1988). Prenatal exposure to nicotine via maternal infusions: Ef-
fects on development of catecholamine systems. Journal of Phar-
macology and Experimental Therapeutics, 244, 940–944. 
Nigg, J. T., & Breslau, N. (2007). Prenatal smoking exposure, 
low birth weight, and disruptive behavior disorders. Journal 
of the American Academy of Child and Adolescent Psychiatry, 46, 
362–369. 
Nugent, J. K., Lester, B. M., Greene, S. M., & Wieczorek-Deering, 
D. (1996). The effects of maternal alcohol consumption and 
cigarette smoking during pregnancy on acoustic cry analysis. 
Child Development, 67, 1806–1815. 
Office of Applied Studies. (2005). Results from the 2004 National 
Survey on Drug Use and Health: National findings (DHHS Publi-
cation No. SMA 05–4062, NSDUH Series H-28). Rockville, MD: 
Substance Abuse and Mental Health Services Administration. 
Picone, T. A., Allen, L. H., Olsen, P. N., & Ferris, M. E. (1982). 
Pregnancy outcome in North American women: II. Effects of 
diet, cigarette smoking, stress, and weight gain on placentas, 
and on neonatal physical and behavioral characteristics. Ameri-
can Journal of Clinical Nutrition, 36, 1214–1224. 
Rantakallio, P. (1983). A follow-up study to the age of 14 of chil-
dren whose mothers smoked during pregnancy. Acta Paediat-
rica Scandinavica, 72, 747–753. 
Richardson, G. A., Day, N. L., & Taylor, P. M. (1989). The effect of 
prenatal alcohol, marijuana, and tobacco exposure on neonatal 
behavior. Infant Behavior and Development, 12, 199–209. 
Richardson, S. A., & Tizabi, Y. (1994). Hyperactivity in the off-
spring of nicotine-treated rats: Role of the mesolimbic and ni-
grostriatal dopaminergic pathways. Pharmacology, Biochemistry 
and Behavior, 47, 331– 337. 
Riese, M. L. (1982). Procedures and norms for assessing behavioral 
patterns in full-term and stable pre-term neonates. JSAS Cata-
log of Selected Documents in Psychology, 12, 6. 
Riese, M. L. (1983). Assessment of behavioral patterns in neonates. 
Infant Behavior and Development, 6, 241–246. 
pr E n atal to b ac c o Ex p o s u rE: DE v E lo p m E n ta l outc o m E s i n th E nE o n ata l pE r i oD   17
Riese, M. L. (1986). Implications of sex differences in neonatal 
temperament for early risk and developmental/environmental 
interactions. Journal of Genetic Psychology, 147, 507–513. 
Riese, M. L. (1987). Temperament stability between the neonatal 
period and 24 months. Developmental Psychology, 23, 216–222. 
Riese, M. L. (1995). Mothers’ ratings of infant temperament: Rela-
tion to neonatal latency to soothe by pacifier. Journal of Genetic 
Psychology, 156, 23–31. 
Riese, M. L., Wilson, R. S., & Matheny, A. P., Jr. (1985). Multi-
method assessment of temperament in twins: Birth to six 
months. Acta Geneticae Medicae et Gemellologiae, 34, 15–31. 
Rodriguez, A., & Bohlin, G. (2005). Are maternal smoking and 
stress during pregnancy related to ADHD symptoms in chil-
dren? Journal of Child Psychology and Psychiatry, 46, 246–254. 
Rogosa, D., & Willett, J. (1985). Understanding the correlates of 
change by modeling individual differences in growth. Psy-
chometrika, 50, 203–228. 
Roza, S. J., Verburg, B. O., Jaddoe, V. W., Hofman, A., Macken-
bach, J. P., & Tiemeier, H. (2007). Effects of maternal smoking 
in pregnancy on prenatal brain development. The Generation 
R Study. European Journal of Neuroscience, 25, 611–617. 
Saxton, D. W. (1978). The behaviour of infants whose mothers 
smoke in pregnancy. Early Human Development, 2, 363–369. 
Schuetze, P., & Eiden, R. (2006). The association between mater-
nal smoking and secondhand exposure and autonomic func-
tioning at 2–4 weeks of age. Infant Behavior and Development, 29, 
32–43. 
Schuetze, P., & Eiden, R. (2007). The association between prenatal 
exposure to cigarettes and infant and maternal negative affect. 
Infant Behavior and Development, 30, 387–398. 
Schuetze, P., Eiden, R., & Dombkowski, L. (2006). The association 
between cigarette smoking during pregnancy and maternal be-
havior during the neonatal period. Infancy, 10, 267–288. 
Seidler, F. J., Levin, E. D., Lappi, S. E., & Slotkin, T. A. (1992). Fetal 
nicotine exposure ablates the ability of postnatal nicotine chal-
lenge to release norepinephrine from rat brain regions. Devel-
opmental Brain Research, 69, 288–291. 
Slotkin, T. A. (1998a). Consensus on postnatal deficits: Compara-
bility of human and animal findings. Annals of the New York 
Academy of Sciences, 846, 153–157. 
Slotkin, T. A. (1998b). Fetal nicotine or cocaine exposure: Which 
one is worse? Journal of Pharmacology and Experimental Therapeu-
tics, 285, 931–945. 
Slotkin, T. A., Greer, N., Faust, J., Cho, H., & Seidler, F. J. (1986). 
Effects of maternal nicotine injections on brain development in 
the rat: Ornithine decarboxylase activity, nucleic acids and pro-
teins in discrete brain regions. Brain Research Bulletin, 17, 41–50. 
Slotkin, T. A., Lappi, S. E., & Seidler, F. J. (1995). Beta-adrenergic 
control of c-fos expression in fetal and neonatal rat tissues: Re-
lationship to cell differentiation and teratogenesis. Toxicology 
and Applied Pharmacology, 133, 188–195. 
Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A tech-
nique for assessing self-reported alcohol consumption. In R. Z. 
Littenand & J. P. Allen (Eds.), Measuring alcohol consumption: 
Psychosocial and biological methods (pp. 41–72). Totowa, NJ: Hu-
mana Press. 
Streissguth, A. P., Sampson, P. D., Barr, H. M., Bookstein, F. L., & 
Carmichael Olson, H. (1994). The effects of prenatal exposure 
to alcohol and tobacco: Contributions of the Seattle Longitu-
dinal Prospective Study and implications for public policy. In 
H. L. Needleman & D. Bellinger (Eds.), Prenatal exposure to toxi-
cants: Developmental consequences (pp. 148–183). Baltimore, MD: 
John Hopkins University Press. 
Stroud, L. R., Paster, R. L., Goodwin, M. S., Shenassa, E., Buka, S., 
Niaura, R., & Lipsitt, L. P. (2009). Maternal smoking during 
pregnancy and neonatal behavior: A large-scale community 
study. Pediatrics, 123, 842–848. 
Stroud, L. R., Paster, R. L., Papandonatos, G. D., Naura, R., Salis-
bury, A. L., Battle, C., & Lester, B. (2009). Maternal smoking 
during pregnancy and newborn neurobehavior: Effects at 10 to 
27 days. Journal of Pediatrics, 154, 4–5. 
Szatmari, P., Saigal, S., Rosenbaum, P., Campbell, D., & King, S. 
(1990). Psychiatric disorders at five years among children with 
birthweights <1000g: A regional perspective. Developmental 
Medicine and Child Neurology, 32, 954–962. 
Thapar, A., Fowler, T., Rice, F., Scourfield, J., van den Bree, M., 
Thomas, H., & Hay, D. (2003). Maternal smoking during preg-
nancy and attention deficit hyperactivity disorder symptoms 
in offspring. American Journal of Psychiatry, 160, 1985–1989. 
Vik, T., Jacobsen, G., Vatten, L., & Bakketeig, L. S. (1996). Pre- and 
post-natal growth in children whose mothers smoked during 
pregnancy. Early Human Development, 45, 245–255. 
Wakschlag, L. S., & Hans, S. L. (2002). Maternal smoking during 
pregnancy and conduct problems in high-risk youth: A de-
velopmental framework. Developmental Psychopathology, 14, 
351–369. 
Wakschlag, L. S., Leventhal, B. L., Pine, D. S., Pickett, K. E., & 
Carter, A. S. (2006). Elucidating early mechanisms of devel-
opmental psychopathology: The case of prenatal smoking and 
disruptive behavior. Child Development, 77, 893–906. 
Wakschlag, L. S., Pickett, K. E., Cook, E., Jr., Benowitz, N. L., & 
Leventhal, B. L. (2002). Maternal smoking during pregnancy 
and severe antisocial behavior in offspring: A review. American 
Journal of Public Health, 92, 966–974. 
Williams, G. M., O’Callaghan, M., Najman, J. M., Bor, W., Ander-
sen, M. J., Richards, D., et al. (1998). Maternal cigarette smok-
ing and child psychiatric morbidity: A longitudinal study. Pe-
diatrics, 102, e11. 
Willoughby, M., Greenberg, M., Blair, C., Stifter, C., & Family Life 
Investigative Group. (2007). Neurobehavioral consequences of 
prenatal exposure to smoking at 6 to 8 months of age, Infancy, 
12, 273–301. 
Woodcock, R. W., McGrew, K. S., & Mather, N. (2001). Woodcock- 
Johnson III Tests of Cognitive Abilities: Brief Intellectual Ability. 
Itasca, IL: Riverside Publishing. 
Yolton, K., Khoury, J., Xu, Y., Succop, P., Lanphear, B., Bernert, 
J. T., & Lester, B. (2009). Low-level prenatal exposure to nico-
tine and infant neurobehavior. Neurotoxicology & Teratology, 31, 
356–363.
